Medicalsystem Biotechnology Co., Ltd.
300439.SZ
Shenzhen Stock Exchange8.49
CNY
-0.14
- -
Medicalsystem Biotechnology Co., Ltd.
300439.SZ
(Shenzhen Stock Exchange)
Recent
price
8.49
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Medicalsystem Biotechnology Co., Ltd. is a China-based company primarily engaged in the research, development, manufacturing, and sale of biochemical reagents, medical laboratory systems, and diagnostic instruments. Its main product lines include biochemical reagents, immunodiagnostic reagents, molecular diagnostics products, clinical automation laboratory systems, and laboratory information management systems. The company offers a comprehensive range of medical diagnostic solutions including clinical chemistry, immunoassay, molecular diagnostics, and in vitro diagnostic (IVD) instruments, serving hospitals, clinical laboratories, and medical institutions across China and internationally. Founded in 2008 and headquartered in Ningbo, Zhejiang Province, Medicalsystem Biotechnology focuses on advancing medical technology integration with a strong emphasis on innovative diagnostic assays and automated testing platforms. In the last two years, Medicalsystem Biotechnology has made strategic advancements, including launching new molecular diagnostic products that broaden its capabilities in infectious disease testing and genetic screening. The company has also increased its global reach through strengthened partnerships with international distributors and expanded its service network overseas, especially in Southeast Asia. Notably, Medicalsystem Biotechnology completed significant investments in upgrading its R&D facilities and production lines to enhance manufacturing capacity and product quality. Additionally, the company has been actively pursuing certifications and regulatory approvals to comply with key markets' standards, which has facilitated recent business expansions and collaborations within the biotech and healthcare sectors. Medicalsystem Biotechnology operates primarily in the biotech and medical diagnostics industry, targeting clinical laboratories, hospitals, and healthcare providers seeking advanced diagnostic reagents and instruments for disease detection and patient health monitoring. Its comprehensive product portfolio and service offerings enable it to cater to a broad spectrum of diagnostic needs ranging from routine clinical testing to cutting-edge molecular diagnostics. The company is headquartered in Ningbo, Zhejiang Province, China, and continues to expand its influence both domestically and internationally through strategic alliances and continuous product innovation. It remains focused on developing integrated diagnostic solutions that enhance clinical decision-making and improve patient outcomes in the healthcare ecosystem.